Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinically relevant findings.

Literature DB >> 9399935

Clinically relevant findings.

T D Gilmore.

Abstract

Mesh：

Substances：

Year: 1997 PMID： 9399935 PMCID： PMC508501 DOI： 10.1172/JCI119843

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

8 in total

1. Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation.

Authors: T S Finco; J K Westwick; J L Norris; A A Beg; C J Der; A S Baldwin
Journal: J Biol Chem Date: 1997-09-26 Impact factor: 5.157

2. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control.

Authors: Z L Chu; T A McKinsey; L Liu; J J Gentry; M H Malim; D W Ballard
Journal: Proc Natl Acad Sci U S A Date: 1997-09-16 Impact factor: 11.205

3. ch-IAP1, a member of the inhibitor-of-apoptosis protein family, is a mediator of the antiapoptotic activity of the v-Rel oncoprotein.

Authors: M You; P T Ku; R Hrdlicková; H R Bose
Journal: Mol Cell Biol Date: 1997-12 Impact factor: 4.272

4. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

Authors: R C Bargou; F Emmerich; D Krappmann; K Bommert; M Y Mapara; W Arnold; H D Royer; E Grinstein; A Greiner; C Scheidereit; B Dörken
Journal: J Clin Invest Date: 1997-12-15 Impact factor: 14.808

5. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer.

Authors: M A Sovak; R E Bellas; D W Kim; G J Zanieski; A E Rogers; A M Traish; G E Sonenshein
Journal: J Clin Invest Date: 1997-12-15 Impact factor: 14.808

6. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo.

Authors: J W Pierce; R Schoenleber; G Jesmok; J Best; S A Moore; T Collins; M E Gerritsen
Journal: J Biol Chem Date: 1997-08-22 Impact factor: 5.157

7. Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines.

Authors: S Miyamoto; P J Chiao; I M Verma
Journal: Mol Cell Biol Date: 1994-05 Impact factor: 4.272

8. Expression of the neoplastic phenotype by human thyroid carcinoma cell lines requires NFkappaB p65 protein expression.

Authors: R Visconti; J Cerutti; S Battista; M Fedele; F Trapasso; K Zeki; M P Miano; F de Nigris; L Casalino; F Curcio; M Santoro; A Fusco
Journal: Oncogene Date: 1997-10-16 Impact factor: 9.867

8 in total

4 in total

Review 1. Molecular and cellular targets.

Authors: Ann M Bode; Zigang Dong
Journal: Mol Carcinog Date: 2006-06 Impact factor: 4.784